Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord blood transfusion and IST in severe aplastic anemia
NCT02745717Phase 4Completed
- Sponsor
- Shanghai General Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of hematopoietic progenitor cells, cord blood in aplastic anemia, sponsored by Shanghai General Hospital. Started Jan 2016; status: completed.
02
Drugs
hematopoietic progenitor cells, cord blood
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02745717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745717.